Despite the benchmark indices, the BSE Sensex and Nifty 50 dropping 2 per cent, Nifty Pharma index has set a new historic peak, surging over 2 per cent so far in the current month.
Shares of Divi's Laboratories, Aurobindo Pharma and Divi's Laboratories continue to hold ground near their recent highs, with no signs of deterioration.
Likewise, Cipla and Glenmark Pharmaceuticals, which have seen tremendous rally recent months, are experiencing accumulation at their immediate supports. Thus, will the current volatility in the benchmark indices offer the ideal opportunity to accumulate pharma stocks? To comprehend this -